A detailed history of Insight Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Insight Wealth Partners, LLC holds 810 shares of LLY stock, worth $672,089. This represents 0.13% of its overall portfolio holdings.

Number of Shares
810
Previous 285 184.21%
Holding current value
$672,089
Previous $221,000 231.67%
% of portfolio
0.13%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $380,556 - $477,246
525 Added 184.21%
810 $733,000
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $168,777 - $225,799
285 New
285 $221,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Insight Wealth Partners, LLC Portfolio

Follow Insight Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Wealth Partners, LLC with notifications on news.